Literature DB >> 19443526

3-Nitrotyrosine inhibits fibroblast-mediated collagen gel contraction and chemotaxis.

H Sugiura1, X Liu, T Ichikawa, M Ichinose, S I Rennard.   

Abstract

Reactive nitrogen species induce tissue inflammation and nitrate tyrosine residues of various kinds of proteins. Recent studies have established that the free amino acid form of 3-nitrotyrosine induces cytotoxity and growth inhibition and alters the cellular function in cultured cells. The aim of this study was to evaluate whether 3-nitrotyrosine could affect tissue remodelling in fibroblasts. To accomplish this, human fetal lung fibroblasts (HFL-1) were used to assess the fibroblast-mediated contraction of floating gels and chemotaxis towards fibronectin. In addition, the ability of fibroblasts to release fibronectin, transforming growth factor (TGF)-beta1, fibronectin and vascular endothelial growth factor (VEGF) was assessed. 3-Nitrotyrosine significantly inhibited gel contraction (p<0.01) compared with control and this inhibition was abolished by nitric oxide synthase (NOS) inhibitor. 3-Nitrotyrosine did not affect TGF-beta1 and VEGF but significantly decreased fibronectin release (p<0.01) into the media. 3-Nitrotyrosine significantly inhibited chemotaxis towards fibronectin through suppression of alpha(5)beta(1) integrin expression (p<0.01). NOS inhibitor also reversed 3-nitrotyrosine-inhibited chemotaxis (p<0.01). Finally, 3-nitrotyrosine enhanced the expression of the inducible type of NOS (p<0.01) and nitric oxide release (p<0.01) through nuclear factor-kappaB activation. These results suggest that the free amino acid form of 3-nitrotyrosine can affect the tissue repair process by modulating nitric oxide production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443526     DOI: 10.1183/09031936.00195808

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  2 in total

1.  Relaxin regulates myofibroblast contractility and protects against lung fibrosis.

Authors:  Xiangwei Huang; Ying Gai; Naiheng Yang; Baogen Lu; Chrishan S Samuel; Victor J Thannickal; Yong Zhou
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

2.  Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.

Authors:  Hesham Basma; Yoko Gunji; Shunichiro Iwasawa; Amy Nelson; Maha Farid; Jun Ikari; Xiangde Liu; Xingqi Wang; Joel Michalski; Lynette Smith; Javeed Iqbal; Radwa El Behery; William West; Sowmya Yelamanchili; Deborah Rennard; Olaf Holz; Kai-Christian Mueller; Helgo Magnussen; Klaus Rabe; Peter J Castaldi; Stephen I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-31       Impact factor: 5.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.